Search results for "Pulmons Malalties"

showing 8 items of 8 documents

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

2022

In the lungs, fibrosis is a growing clinical problem that results in shortness of breath and can end up in respiratory failure. Even though the main fibrotic disease affecting the lung is idiopathic pulmonary fibrosis (IPF), which affects the interstitial space, there are many fibrotic events that have high and dangerous consequences for the lungs. Asthma, chronic obstructive pulmonary disease (COPD), excessive allergies, clearance of infection or COVID-19, all are frequent diseases that show lung fibrosis. In this review, we describe the different kinds of fibrosis and analyse the main types of cells involved—myofibroblasts and other cells, like macrophages—and review the main fibrotic mec…

Aparell respiratori MalaltiesMedicine (miscellaneous)General Biochemistry Genetics and Molecular BiologyPulmons MalaltiesBiomedicines
researchProduct

Intraoperative ventilator settings and their association with postoperative pulmonary complications in neurosurgical patients: Post-hoc analysis of L…

2020

Abstract Background Limited information is available regarding intraoperative ventilator settings and the incidence of postoperative pulmonary complications (PPCs) in patients undergoing neurosurgical procedures. The aim of this post-hoc analysis of the ‘Multicentre Local ASsessment of VEntilatory management during General Anaesthesia for Surgery’ (LAS VEGAS) study was to examine the ventilator settings of patients undergoing neurosurgical procedures, and to explore the association between perioperative variables and the development of PPCs in neurosurgical patients. Methods Post-hoc analysis of LAS VEGAS study, restricted to patients undergoing neurosurgery. Patients were stratified into g…

Lung DiseasesMaleSURGERYmedicine.medical_treatment[SDV]Life Sciences [q-bio]RESPIRATORY-DISTRESS-SYNDROMEBRAIN-INJURYNeurosurgical ProceduresPositive-Pressure Respiration0302 clinical medicinePostoperative ComplicationsMechanical ventilation030202 anesthesiologyInterquartile rangeMedicine and Health SciencesGeneral anaesthesiaEND-EXPIRATORY-PRESSUREProspective StudiesPostoperative pulmonaryPostoperative pulmonary complicationsMiddle Aged3. Good health[SDV] Life Sciences [q-bio]AnesthesiaFemaleNeurosurgeryResearch ArticlePulmons MalaltiesAdultmedicine.medical_specialtycomplicationsNeurosurgeryLung injuryAnesthesia GeneralLAS VEGAS; Mechanical ventilation; Neurosurgery; Postoperative pulmonary complications;NOlcsh:RD78.3-87.3LAS VEGAS ; Mechanical ventilation ; Neurosurgery ; Postoperative pulmonary complications.03 medical and health sciencesNeurologiaLAS VEGASAnesthesiologymedicineTidal VolumeHumansMED/41 - ANESTESIOLOGIAHIGH TIDALAgedMechanical ventilationIntraoperative CareVentilators MechanicalCirurgiabusiness.industry030208 emergency & critical care medicineOdds ratioPerioperativeRespiration ArtificialAnesthesiology and Pain Medicinelcsh:AnesthesiologyVOLUMELAS VEGAS; Mechanical ventilation; Neurosurgery; Postoperative pulmonary complicationsbusinessPostoperative pulmonary complicationLUNG INJURY
researchProduct

Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency

2021

This work was co-financed by the European Union through the Operational Programme of the European Regional Development Fund of Valencia Region (Spain) 2014–2020.

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industryCommon variable immunodeficiencySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19General Medicinemedicine.diseaseVirologyCommon Variable ImmunodeficiencyInfectious DiseasesClinical recurrencemedicineHumansbusinessLetter to the EditorPulmons Malalties
researchProduct

Synthetic Pulmonary Surfactant Preparations: New developments and future trends

2008

Pulmonary surfactant is a lipid-protein complex that coats the interior of the alveoli and enables the lungs to function properly. Upon its synthesis, lung surfactant adsorbs at the interface between the air and the hypophase, a capillary aqueous layer covering the alveoli. By lowering and modulating surface tension during breathing, lung surfactant reduces respiratory work of expansion, and stabilises alveoli against collapse during expiration. Pulmonary surfactant deficiency, or dysfunction, contributes to several respiratory pathologies, such as infant respiratory distress syndrome (IRDS) in premature neonates, and acute respiratory distress syndrome (ARDS) in children and adults. The ma…

Models MolecularARDSmedicine.medical_specialtyMolecular Sequence DataAcute respiratory distressPharmacologyBiochemistryStructure-Activity RelationshipPulmonary surfactantDrug DiscoveryAnimalsHumansMedicineAmino Acid SequenceRespiratory systemPharmacologyRespiratory distressbusiness.industryOrganic ChemistryRespiratory diseasePulmonary Surfactantsmedicine.diseaseLipidsSurgeryDuring expirationBreathingMolecular MedicinebusinessProteïnesPulmons Malalties
researchProduct

The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN

2022

Primary ciliary dyskinesia; Rare genetic disorder; Lung diseases Discinesia ciliar primaria; Trastorno genético raro; Enfermedades pulmonares Discinesia ciliar primària; Trastorn genètic rar; Malalties pulmonars Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterised by impaired mucociliary clearance leading to irreversible lung damage. In contrast to other rare lung diseases like cystic fibrosis (CF), there are only few clinical trials and limited evidence-based treatments. Management is mainly based on expert opinions and treatment is challenging due to a wide range of clinical manifestations and disease severity. To improve clinical and translational research and facili…

Pulmonary and Respiratory Medicine:enfermedades respiratorias::trastornos de la motilidad ciliar [ENFERMEDADES]:Health Occupations::Medicine::Pediatrics [DISCIPLINES AND OCCUPATIONS]Respiratory SystemSağlık BilimleriClinical Medicine (MED)SOLUNUM SİSTEMİRespiratory CareHealth SciencesMANAGEMENTKlinik Tıp (MED)Chest Diseases and Allergy:profesiones sanitarias::medicina::pediatría [DISCIPLINAS Y OCUPACIONES]:Otros calificadores::/terapia [Otros calificadores]:Respiratory Tract Diseases::Ciliary Motility Disorders [DISEASES]Internal Medicine SciencesScience & TechnologyKlinik TıpMUTATIONSRESPIRATORY SYSTEM:Other subheadings::/therapy [Other subheadings]Dahili Tıp BilimleriGöğüs Hastalıkları ve AllerjiCLINICAL MEDICINECèl·lules - Motilitat:Congenital Hereditary and Neonatal Diseases and Abnormalities::Genetic Diseases Inborn [DISEASES]TıpPulmons - Malalties - TractamentAkciğer ve Solunum TıbbıMedicineMalalties congènites:enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas [ENFERMEDADES]Solunum BakımıLife Sciences & BiomedicinePulmons Malalties
researchProduct

Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.

2014

Abstract Background Epithelial to mesenchymal transition (EMT) is under discussion as a potential mechanism of small airway remodelling in COPD. In bronchial epithelium of COPD and smokers markers of EMT were described. In vitro, EMT may be reproduced by exposing well-differentiated human bronchial epithelial cells (WD-HBEC) to cigarette smoke extract (CSE). EMT may be mitigated by an increase in cellular cAMP. Objective This study explored the effects of roflumilast N-oxide, a PDE4 inhibitor on CSE-induced EMT in WD-HBEC and in primary bronchial epithelial cells from smokers and COPD in vitro. Methods WD-HBEC from normal donors were stimulated with CSE (2.5%) for 72 h in presence of roflum…

Pulmonary and Respiratory MedicineCyclopropanesMalePathologymedicine.medical_specialtyEpithelial-Mesenchymal TransitionAminopyridinesVimentinApoptosisBronchiEnzyme-Linked Immunosorbent AssayRespiratory MucosaIn Vitro TechniquesTransforming Growth Factor beta1Pulmonary Disease Chronic ObstructiveAnnexinSmokemedicineCyclic AMPHumansPharmacology (medical)Epithelial–mesenchymal transitiontabac efectes fisiològicsRoflumilastAgedchemistry.chemical_classificationReactive oxygen speciesbiologybusiness.industryBiochemistry (medical)Mesenchymal stem cellSmokingNOX4Epithelial CellsfarmacologiaMiddle Agedrespiratory tract diseaseschemistryApoptosisBenzamidesbiology.proteinCancer researchFemalePhosphodiesterase 4 Inhibitorspulmons malalties obstructivesbusinessReactive Oxygen Speciesmedicine.drugPulmonary pharmacologytherapeutics
researchProduct

Telomerase and Telomere Length in Pulmonary Fibrosis

2013

In addition to its expression in stem cells and many cancers, telomerase activity is transiently induced in murine bleomycin (BLM)-induced pulmonary fibrosis with increased levels of telomerase transcriptase (TERT) expression, which is essential for fibrosis. To extend these observations to human chronic fibrotic lung disease, we investigated the expression of telomerase activity in lung fibroblasts from patients with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). The results showed that telomerase activity was induced in more than 66% of IPF lung fibroblast samples, in comparison with less than 29% from control samples, some of which were obtained from lu…

Pulmonary and Respiratory MedicineMaleTelomerasePathologymedicine.medical_specialtyClinical BiochemistryBiologyBleomycinGene Expression Regulation EnzymologicHistonesTelomerase RNA componentIdiopathic pulmonary fibrosischemistry.chemical_compoundBleomycinMiceFibrosisPulmonary fibrosismedicineAnimalsHumansEmfisema pulmonarPromoter Regions GeneticMolecular BiologyLungTelomeraseCells CulturedMice KnockoutLungAntibiotics AntineoplasticAcetylationCell BiologyArticlesFibroblastsTelomererespiratory systemmedicine.diseaseIdiopathic Pulmonary FibrosisTelomereUp-Regulationrespiratory tract diseasesmedicine.anatomical_structurechemistryPulmonsChronic DiseaseCancer researchFemaleAlveolitis Extrinsic AllergicPulmons Malalties
researchProduct

Inspiratory muscle training combined with pursed lip technique in women with chronic osbtructive pulmonary disease: a case study.

2020

Objective. To improve pulmonary function, exercise capacity and quality of life of two women with Chronic Obstructive Pulmonary Disease (COPD). Material and Methods. Study of two clinical cases, both women. An intervention of 8 weeks was performed, in which the patients performed 3 weekly sessions, of which 1 was performed with supervision of the physiotherapist and 2 sessions were performed at home. The treatment sessions consisted of inspiratory muscle training with an inspiratory threshold and controlled breathing exercises with the pursed lip technique. Results. Quality of life of both women improved at the end of the study. In the woman with severe COPD, Maximal Inspiratory Pressure (M…

medicine.medical_specialtyFisioteràpiaAerospace EngineeringPulmonary diseaseSevere copdchronic obstructive pulmonary diseasePulmonary function testinglcsh:GV557-1198.995Quality of lifeMedicinelcsh:Sports medicinepursed liplcsh:SportsCOPDinspiratory muscle trainingControlled breathingbusiness.industryInspiratory muscle trainingExercise capacitymedicine.diseaserespiratory tract diseasesrespiratory physiotherapyPhysical therapylcsh:RC1200-1245businessPulmons Malalties
researchProduct